190 related articles for article (PubMed ID: 38638675)
1. The malignant transformation potential of the oncogene STYK1/NOK at early lymphocyte development in transgenic mice.
Yang Y; Liu L; Tucker HO
Biochem Biophys Rep; 2024 Jul; 38():101709. PubMed ID: 38638675
[TBL] [Abstract][Full Text] [Related]
2. Induction of chronic lymphocytic leukemia-like disease in STYK1/NOK transgenic mice.
Yang Y; Liu L; Tucker HO
Biochem Biophys Res Commun; 2022 Oct; 626():51-57. PubMed ID: 35970044
[TBL] [Abstract][Full Text] [Related]
3. STYK1/NOK affects cell cycle late mitosis and directly interacts with anaphase-promoting complex activator CDH1.
Zeng SL; Patel SS; Lv MQ; Zhu D; Shen WH; Liu L
Heliyon; 2022 Dec; 8(12):e12058. PubMed ID: 36506394
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of GLUT3 impairs STYK1/NOK-mediated metabolic reprogramming and proliferation in NIH-3T3 cells.
Shi W; Fu Y; Wang Y
Oncol Lett; 2021 Jul; 22(1):527. PubMed ID: 34055092
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic relevance of overexpressed serine threonine tyrosine kinase/novel oncogene with kinase domain (STYK1/ NOK) mRNA in colorectal cancer.
Orang AV; Safaralizadeh R; Hosseinpour Feizi MA; Somi MH
Asian Pac J Cancer Prev; 2014; 15(16):6685-9. PubMed ID: 25169509
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia.
Kondoh T; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Exp Hematol; 2009 Jul; 37(7):824-30. PubMed ID: 19409952
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.
Kay NE; Peterson L
Leuk Lymphoma; 1991; 5(1):49-55. PubMed ID: 27463209
[TBL] [Abstract][Full Text] [Related]
9. Biological Features of CD5+ CD19+ B1 Cell and Natural IgM (VH4-34) in Chronic Lymphocytic Leukemia vs. Multiple Sclerosis.
Pezeshki S; Jazayeri MH; Chahardouli B; Tajik N; Nabavi SM; Akbarzadeh M
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):670-676. PubMed ID: 36640058
[TBL] [Abstract][Full Text] [Related]
10. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
11. A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment.
Kimbro KS; Duschene K; Willard M; Moore JA; Freeman S
Mol Biol Rep; 2008 Mar; 35(1):23-7. PubMed ID: 17415682
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
Ryder CB; Oduro KA; Moore EM
Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
[TBL] [Abstract][Full Text] [Related]
13. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
Darwiche W; Gubler B; Marolleau JP; Ghamlouch H
Front Immunol; 2018; 9():683. PubMed ID: 29670635
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of chronic lymphocytic leukemia and human B1 cell development.
Kikushige Y
Int J Hematol; 2020 May; 111(5):634-641. PubMed ID: 31797231
[TBL] [Abstract][Full Text] [Related]
15. Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia.
Gahn B; Schäfer C; Neef J; Troff C; Feuring-Buske M; Hiddemann W; Wörmann B
Blood; 1997 Jun; 89(12):4275-81. PubMed ID: 9192749
[TBL] [Abstract][Full Text] [Related]
16. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
17. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.
Hayakawa K; Formica AM; Brill-Dashoff J; Shinton SA; Ichikawa D; Zhou Y; Morse HC; Hardy RR
J Exp Med; 2016 Dec; 213(13):3007-3024. PubMed ID: 27899442
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.
Ghia P; Prato G; Scielzo C; Stella S; Geuna M; Guida G; Caligaris-Cappio F
Blood; 2004 Mar; 103(6):2337-42. PubMed ID: 14630808
[TBL] [Abstract][Full Text] [Related]
19. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
[TBL] [Abstract][Full Text] [Related]
20. NOK/STYK1 promotes the genesis and remodeling of blood and lymphatic vessels during tumor progression.
Liu Y; Li T; Hu D; Zhang S
Biochem Biophys Res Commun; 2016 Sep; 478(1):254-259. PubMed ID: 27444381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
